In Vivo Studies
Translating Science Into Safe, Effective Therapies
At BP Clinical, our in vivo research capabilities are a vital part of preclinical drug development. We provide high-quality, ethically conducted in vivo studies to assess the pharmacokinetics, pharmacodynamics, toxicity, and efficacy of investigational compounds in live models. These studies generate critical data that guide formulation, dosing, and clinical trial readiness — ensuring only the most promising candidates advance to human trials.
We specialize in in vivo BA/BE studies with advanced facilities and scientific expertise to meet international standards. Our team conducts high-quality in vivo clinical trials in India, ensuring accuracy, safety, and compliance at every stage. With deep experience in in vivo pharmacokinetic studies, we deliver precise data to support drug development and regulatory needs. As a global partner, we provide complete solutions for in vivo studies for global submissions, helping pharmaceutical companies achieve faster approvals worldwide.
What Are In Vivo Studies?
In vivo studies involve testing in live organisms to understand how a drug behaves within a living system. These studies provide essential data on:
Our In Vivo Capabilities
BP Clinical’s preclinical division offers comprehensive in vivo services for small molecules, biologics, and complex generics:
Single/multiple-dose PK studies
Bioavailability and bio-distribution assessments
PK/PD correlation for early-stage validation
Acute, sub-acute, sub-chronic, and chronic toxicity
NOAEL determination
GLP-compliant protocols and reporting
Custom animal models for oncology, inflammation, neurology, metabolic disorders, and more
Biomarker analysis and therapeutic impact assessment
Route of administration: oral, IV, IP, SC, IM, topical
Dose-ranging and tolerability studies
